Brief: Sipai Health Technology Says Bixun Pharmaceutical To Buy Shanze Technology
18/03/2026 14:03
March 18 (Reuters) - Sipai Health Technology Co, Ltd 0314.HK: BIXUN PHARMACEUTICAL TO BUY SHANZE TECHNOLOGY DEAL FOR RMB354.5 MILLION BASE CONSIDERATION Further company coverage: 0314.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sipai Health Technology Co,
See all newsBrief: Sipai Health Technology's Unit Disposes 100% Stake In Sipai Zhihe Technology (Guangzhou) Co
Brief: Sipai Health Technology Says Bixun Pharmaceutical To Buy Shanze Technology
Brief: Sipai Health Technology Expects Normalized Net Loss Of No More Than RMB50 MLN For FY
Brief: Sipai Health Technology Subscribes To Wealth Management Product From JPM
Brief: Sipai Health Technology Redeems Wealth Management Product For $23.7 Million